Negotiating healthy trade in Australia: health impact assessment of the proposed Trans-Pacific Partnership Agreement

Drawing on leaked texts of potential provisions of the proposed Trans-Pacific Partnership Agreement, this health impact assessment found the potential for negative impacts in the cost of medicines, tobacco control policies, alcohol control policies, and food labeling. Overview The Centre for Health Equity Training Research and Evaluation (CHETRE) has been working with a group of Australian academics and non-government organisations interested in the health of the Australian population to carry out a health impact assessment (HIA) on the Trans-Pacific Partnership Agreement (TPP) negotiations. In the absence of official publicly available drafts of the trade agreement, the health impact assessment drew on leaked texts of potential provisions and formulated policy scenarios based on high priority health policies that could be affected by the TPP. The HIA found the potential for negative impacts in each of the four areas under investigation: the cost of medicines; tobacco control policies; alcohol control policies; and food labeling. In each of these areas, the HIA report traces the relevant proposed provisions through to their likely effects on the policy scenarios onto the likely impact on the health of Australians, focusing particularly on vulnerable groups in the Australian community. The report makes a number of recommendations to DFAT regarding the TPP provisions and to the Australian Government regarding the TPP negotiating process

Making an impact: The influence of policies to reduce emissions from aviation on the business travel patterns of individual corporations

The contribution of aviation to global carbon dioxide (CO2) emissions is projected to triple by 2050. As nations strive to meet CO2 reduction targets, policy interventions to manage the growth of emissions arising from air travel are likely. Here, we investigate the potential influence of aviation emissions reduction policies on the business travel patterns of individual corporations. Using travel data from six UK-based companies, we find that increased ticket prices can deliver substantial emissions cuts, particularly on premium class flights, and may provide strong financial incentives to seek modal and/or technological alternatives to flying. We also find that corporations from different business sectors vary in their responsiveness to arange of policy options. Finally, we examine questionnaire data to determine whether companies more broadly are going beyond compliance to mitigate their environmental impact by managing travel-related emissions voluntarily. Although many corporations are measuring and reporting emissions, only a limited number are willing to implement in-house reduction policies prior to regulation

EMPLOYMENT IN BIOTECHNOLOGY IN GERMANY

Paper prepared for presentation at the 8th ICABR International Conference on Agricultural Biotechnology: International Trade and Domestic Production Ravello (Italy), July 8 to 11th, 2004Biotechnology, Employment, Germany, Application industries, Simulation, Labor and Human Capital, E24, J21,

Sustained spending and persistent response: a new look at long-term marketing profitability.

An intuitively appealing decision rule is to allocate a company's scarce marketing resources where they have the greatest long-term benefit. This principle, however, is easier to accept than it is to execute, because long-run effects of marketing spending are difficult to estimate. We address this problem by examining the over-time behavior of market response and marketing spending, and identify four commonly occurring strategic scenarios: business as usual, hysteresis in response, escalating expenditures and evolving-business practice. We explain and illustrate why each scenario can occur in practice, and describe its positive and negative consequences for long-term profitability.When good time-series data on revenue and marketing spending are available, it is possible to apply multivariate persistence measures to identify which of the four strategic scenarios is taking place. We apply these ideas to data from two major companies in the packaged-foods and pharmaceuticals industries. We observe several long-term marketing effect, some with profitable and some with unprofitable consequences, and offer recommendations for each case.We conclude that high-quality databases along with modern time-series methods can be instrumental in extracting vital long-term marketing-effectiveness information from readily available data. Therefore, managing marketing resources with long-run performance in mind need no longer be a pure act of faith on behalf of the executive. We hope that this and future work will contribute toward an improved allocation of scarce marketing resources in our companies.Marketing; Profitability;

Using electronic health records to support clinical trials: a report on stakeholder engagement for EHR4CR

Background. The conduct of clinical trials is increasingly challenging due to greater complexity and governance requirements as well as difficulties with recruitment and retention. Electronic Health Records for Clinical Research (EHR4CR) aims at improving the conduct of trials by using existing routinely collected data, but little is known about stakeholder views on data availability, information governance, and acceptable working practices. Methods. Senior figures in healthcare organisations across Europe were provided with a description of the project and structured interviews were subsequently conducted to elicit their views. Results. 37 structured interviewees in Germany, UK, Switzerland, and France indicated strong support for the proposed EHR4CR platform. All interviewees reported that using the platform for assessing feasibility would enhance the conduct of clinical trials and the majority also felt it would reduce workloads. Interviewees felt the platform could enhance trial recruitment and adverse event reporting but also felt it could raise either ethical or information governance concerns in their country. Conclusions. There was clear support for EHR4CR and a belief that it could reduce workloads and improve the conduct and quality of trials. However data security, privacy, and information governance issues would need to be carefully managed in the development of the platform

Global supply chains of high value low volume products

Imperial Users onl

R&D and knowledge dynamics in university-industry relationships in biotech and pharmaceuticals: An agent-based model

In the last two decades, University-Industry Relationships have played an outstanding role in shaping innovation activities in Biotechnology and Pharmaceuticals. Despite the growing importance and the considerable scope of these relationships, there still is an intensive and open debate on their short and long term effects on the research system in life sciences. So far, the extensive literature on this topic has not been able to provide a widely accepted answer. This work introduces a new way to analyse University-Industry Relationships (UIRs) which makes use of an agent-based simulation model. With the help of simulation experiments and the comparison of different scenario results, new insights on the effects of these relationships on the innovativeness of the research system can be gained. In particular, focusing on knowledge interactions among heterogeneous actors, we show that: (i) universities tend to shift from a basic to an applied research orientation as a consequence of relationships with industry, (ii) universities' innovative capabilities benefit from industry financial resources but not so much from cognitive resources of the companies, (iii) biotech companies' innovative capabilities largely benefit from the knowledge interaction with universities and (iv) adequate policies in terms of public basic research funding can contrast the negative effects of UIRs on university research orientation. --University-Industry Relationships,Knowledge Dynamics,University Patenting,Technology Transfer,Agent-Based Modelling

Production and employment impacts of new technologies: analysis for biotechnology

Biotechnology is often regarded as a key technology with high potential for far-reaching social, environmental and economic impacts. Among others, the development and diffusion of biotechnology may have considerable economic effects on production and employment. This paper analyzes the economic impacts of different diffusion paths of biotechnology in some major application fields. Bottom-up technology information from literature, expert judgements and explicit scenario assumptions for various impact factors are combined and integrated in an input-output framework to calculate direct and indirect production and employment effects. The impact on net production and employment differs greatly between the different application sectors and depends on the respective importance of the various impact mechanisms. The indirect economic effects are rather high and exceed direct economic effects. These findings show the importance of a bottom-up approach as well as the consideration of indirect economic effects for appropriate analyses of the impact of biotechnology. --Economic impacts of technologies,employment effects,input-output model,biotechnology